Technical Signals Emerge for HEMIPROP and SUMICHEM

Geojit Investments' chief market strategist Anand James has identified technical buy signals for Hemisphere Properties India (HEMIPROP) and Sumitomo Chemical India (SUMICHEM). HEMIPROP's charts show a potential move from a downturn to an upturn, with rising lows and a Supertrend breakout. For SUMICHEM, breaking its weekly Supertrend signal combined with positive monthly reversal candles suggests a trend reversal from a downturn. While these technical shifts are important, a full investment picture requires looking at each company's financial health and industry conditions.

HEMIPROP: Technical Gains Clash with Financial Weakness

Hemisphere Properties India (HEMIPROP) is trading around ₹135. Geojit Investments finds its technical setup positive, citing a Supertrend breakout and consistently higher lows since April, along with a bullish MACD crossover on the weekly chart. However, its fundamentals present a starkly different picture. As of late April 2026, HEMIPROP has a negative P/E ratio of -346.76, reflecting ongoing net losses, including ₹3.24 crore in the December 2025 quarter and ₹3.46 crore in the March 2026 quarter. Its book value per share is ₹15.43, making the current price appear very high by traditional valuation standards. HEMIPROP, a Government of India enterprise focused on land monetization, has filed routine SEBI compliance documents. Despite positive technical signals, the stock's price has recently declined. Technical analysis also notes sell signals from pivot tops, suggesting a potential drop to ₹96.07-₹119.62 over the next three months. Competitors like DLF and Godrej Properties, while also affected by market swings, have positive earnings and stronger market positions. While India's real estate sector is expected to grow steadily in 2026 due to demand and policy reforms, HEMIPROP's financial health and valuation pose significant challenges for sustained gains beyond short-term technical moves.

SUMICHEM: Strong Fundamentals Support Technical Reversal

Sumitomo Chemical India (SUMICHEM) offers a more positive outlook, with technical indicators suggesting a potential trend reversal backed by solid fundamentals. Trading near ₹449, the stock is nearing a breakout of its weekly Supertrend, supported by monthly reversal candles and easing MACD bearish momentum. Fundamentally, SUMICHEM has a market capitalization of ₹22,411.60 crore as of April 2026 and a P/E ratio of around 39.4. This P/E, while high, is justified by consistent profits. In fiscal year 2025, revenue rose 10.71% to ₹31.49 billion and earnings grew 36.79% to ₹5.05 billion. The company is debt-free with strong returns, showing an ROE of 18.81%. Analyst targets for SUMICHEM are ₹440-₹500 for 2026, with some forecasting up to ₹565 as a 1-year average. India's chemical industry is seeing strong growth, forecast at 10.9% in 2026, driven by domestic demand and government backing, particularly in specialty chemicals. Competitors like UPL and PI Industries operate in similar growth conditions. SUMICHEM's focus on R&D-driven products, global reach, and backing from Sumitomo Chemical Company, Japan, strengthens its position. ICICI Securities initiated coverage with a 'Buy' rating and ₹515 target, citing strong parent backing and aggressive capital spending plans.

Key Risks: HEMIPROP's Losses vs. SUMICHEM's Valuation

For HEMIPROP: The main concern for Hemisphere Properties India is its ongoing unprofitability and negative P/E ratio, showing it's not earning enough relative to its market value. Its operational revenue is minimal, with net sales reported at just ₹0.26 crore in the December 2025 quarter. As a government enterprise, decision-making and asset monetization might face bureaucratic delays, potentially limiting its agility compared to private competitors like DLF or Godrej Properties, which consistently achieve profits and have stronger balance sheets. While technical breakouts can offer short-term trading chances, the lack of earnings support makes the stock highly speculative. Some analyses suggest it's overvalued by 94 percent, with technical indicators showing sell signals.

For SUMICHEM: Sumitomo Chemical India's main risk is its valuation. A P/E ratio around 39.4 is high for the chemical sector, suggesting its future growth is largely priced in. Any slowdown in its projected 15.3% annual earnings growth or unexpected regulatory issues could cause a sharp price drop. While the company is debt-free, its reliance on strong export demand and volatile global commodity prices pose external risks. Analyst targets have also seen decreases, indicating that the upside may be limited for aggressive investors. Mr. Yoshihisa Inoue ceasing his deputation might cause an adjustment period, though large corporations usually manage such changes smoothly. The market consensus is 'hold' at current levels, advising caution before new investments.

Outlook for Real Estate and Chemicals Sectors

India's real estate sector, including companies like Hemisphere Properties, is expected to keep growing in 2026, driven by urbanization and policy support. However, HEMIPROP's path forward will likely depend on its ability to turn land assets into profitable ventures, a prospect still uncertain given its financial history. For Sumitomo Chemical India, the outlook is largely positive, boosted by the strong growth of India's chemical industry, projected at 10.9% in 2026. Its focus on specialty chemicals, strong parentage, and R&D investments position it well to capture this expansion, but investors should note its current high valuation multiples and global economic sensitivities.